Annette Gerritsen

Annette Gerritsen is an active Researcher in the Department of Medical Oncology at Erasmus MC, Erasmus University Rotterdam, specializing in hereditary cancer syndromes with focus on Breast Cancer, Ovarian Cancer, and BRCA1/2 mutation carriers. Her work bridges oncology and cardiovascular outcomes in high-risk populations.

Her research interests center on cancer risk assessment in genetic syndromes, particularly examining contralateral cancer development, salpingo-oophorectomy outcomes, and multi-site cancer risks in CHEK2 families. Current work investigates cardiovascular implications of risk-reducing surgeries using advanced imaging techniques.

Recent publications (2024-2025) reveal a strong focus on cardio-oncology interfaces, with multiple studies analyzing arterial stiffness and coronary calcium scores post-salpingo-oophorectomy in BRCA carriers. Her work consistently employs multicenter prospective designs and radiological biomarker analysis.

Scientific contributions:

• Active contributor to The Hereditary Breast and Ovarian Cancer Research Group Netherlands
• ORCID: 0000-0002-9724-6693
• 44 total research outputs including 41 articles

She has supervised at least one doctoral project and collaborates extensively with national consortia including Ausems, van Leeuwen, and Maas groups. Current work emphasizes longitudinal monitoring of surgical risk-reduction outcomes and genetic risk stratification models.